Antibodies play a vital role in research, diagnostics, and therapeutic development, making their purity and quality crucial for accurate and reliable outcomes. The antibody purification process combines scientific precision with methodical expertise, requiring researchers to select the right techniques tailored to their antibodies’ unique properties.

Purified antibodies are employed in various applications, including diagnostic assays like enzyme-linked immunosorbent assay (ELISA), western blotting (WB) immunocytochemistry (ICC), flow cytometry (FC) and immunohistochemistry (IHC), as well as therapeutic uses such as immunotherapy and clinical research. They are also essential for chemical modifications, protein purification, and enhancing reproducibility in scientific research and imaging.

This article explores the science behind antibody purification, breaking down the principles, techniques, and factors that contribute to its success. Whether you're working with monoclonal or polyclonal antibodies, understanding the nuances of purification is key to achieving optimal results.

Purification of various types of antibodies

Different types of antibodies, such as monoclonal, polyclonal, and recombinant, require tailored purification strategies to achieve optimal results. Each type comes with unique challenges based on its source, structure, and intended application. Here's an overview of the approaches used for purifying these antibodies:

Monoclonal antibodies

Monoclonal antibody (mAb) production starts with hybridoma technology for antibody production. Traditional purification methods such as ammonium sulfate precipitation or protein A/G affinity chromatography follow this offering a non-bio-specific approach. Recent advancements, such as new resin technologies and in vitro systems, have significantly improved the process and reduced time and labor while enhancing the yield and purity of mAbs for therapeutic and diagnostic use.

Polyclonal antibodies

Polyclonal antibodies (pAbs) can be purified from serum using a biospecific approach, such as affinity chromatography with synthetic ligands and non-affinity polymers, providing high purity and yield. Preparative electrophoresis is a promising alternative, offering over 80% recovery from various serum sources, making it a reliable option when reactivity with protein A, G, or L is uncertain. Additionally, precipitation and ion exchange chromatography can also be used for purification.

Recombinant antibodies

The purification of recombinant antibodies varies depending on the expression system—mammalian cells, bacteria, yeast, or insect cells—each having unique considerations. Mammalian systems are favored for therapeutic antibodies due to human-like glycosylation, while bacterial systems offer high yields for smaller fragments. Yeast and insect cells balance yield and quality, and all require specific purification strategies, such as ion exchange chromatography and affinity chromatography, to ensure high purity and functionality.

Bispecific antibodies

Bispecific antibodies (bsAbs) present unique challenges in downstream processing due to their specific byproducts, such as mispaired products and higher levels of aggregates, which require additional purification strategies beyond those used for mAbs. While current purification processes are adapted from mAb processes, innovations like differential affinity chromatography and multistep elutions are essential for achieving high purity and yield in bsAb production. Furthermore, to separate aggregates from the desired product, steps like size exclusion chromatography can be performed.

Pre-purification steps

Sample preparation: Pre-purification steps, including cell lysis, centrifugation, filtration, and buffer exchange, are essential for preparing samples for high-quality antibody purification. Automated and integrated systems enhance efficiency by reducing impurities and improving yield, with techniques like continuous centrifugal diafiltration and depth filtration significantly optimizing the pre-purification process. If using a protein purification system chromatography column hardware, it is vitally important to filter and source material to extend the life of any equipment or consumables.

Source considerations: The choice of source material, such as cell culture supernatants, serum, or recombinant expression systems, significantly impacts the efficiency, yield, and purity of monoclonal antibody purification. While cell culture supernatants and recombinant systems are preferred for scalability and high-purity production, serum poses challenges due to non-IgG proteins, necessitating tailored purification with multistep approaches for optimal results.

Common methods for antibody purification

Antibody purification relies on a variety of techniques to isolate antibodies from complex mixtures while preserving their functionality. The choice of method depends on factors like antibody type, source, and intended application. Here are some of the most used purification methods:

Chromatography

Chromatography is a vital technique in antibody purification. It uses methods like affinity, ion exchange, and size exclusion chromatography to separate and purify antibodies based on their specific interactions, charge, or size.

Affinity chromatography

Affinity chromatography is a widely used method for antibody purification, relying on specific interactions between antibodies and immobilized ligands to achieve high purity levels. It is widely used for antibody purification through proteins A, G, and L, with guidance on techniques and selection provided for monoclonal, polyclonal, and recombinant antibodies.

• Specific Antigen/ligand affinity chromatography: Highly specific antibodies will be bound to a bead-based resin through their antigen-binding sites, which are typically coated with the same antigen or ligand used for immunization. Examples of these can be peptides or full-length proteins.
• Protein A/G/L affinity chromatography: Proteins A, G, and L bind antibodies through interactions with Fc regions and light chains, with protein A primarily targeting IgG's Fc region, protein G binding both Fc and light chains, and protein L specifically interacting with certain subtypes of the kappa light chains. Hybrid proteins like protein LG and LA combine these binding properties, enhancing their affinity and versatility for various immunoglobulin classes across species.

Protein A is widely used for IgG purification or monoclonal antibody by binding the antibody Fc region, while protein L specifically binds kappa light chains, enabling the purification of antibodies with this light chain type. Recent studies have uncovered novel interactions between protein L and antibody regions, with modifications in kappa light chain-binding polypeptides improving binding efficiency and expanding its versatility in antibody applications.

Protein A and protein G are widely used for antibody purification due to their stability and selectivity. These proteins interact with IgG antibodies from various species, enabling efficient antibody capture using protein-coated beads. Their binding affinities vary depending on the species and the characteristics of the antibody's heavy chain. The chart below outlines the binding affinities of protein A and protein G for different immunoglobulin subtypes across species.

Key: ++++, Strong binding; +++, Moderate binding; ++, Weak binding; +/-, Variable binding; +, Very weak binding; -, No binding

Applications of affinity chromatography in antibody isolation from serum: The proteomics method isolates antigen-specific antibodies from serum by affinity purification, followed by analysis to identify antibody sequences and produce recombinant monoclonal antibodies. It enables the generation of highly specific monoclonal antibodies, useful for vaccine development and antibody-based therapies.

For streamlined and efficient antibody purification, options like protein A and protein G-based kits can be particularly useful. For eg, protein A antibody purification kits (ab288103) are ideal for isolating IgG antibodies with high specificity, while serum antibody purification kits are designed to simplify the process of working with serum samples. Similarly, antibody purification kit-protein G (ab128747) offers an effective alternative for antibodies with a stronger affinity for protein G, catering to diverse purification needs.

Ion exchange chromatography (IEC)

Anion exchange chromatography (AEC) uses positively charged stationary phases to attract and bind negatively charged molecules (anions), while cation exchange chromatography (CEC) employs negatively charged stationary phases to retain positively charged molecules (cations). Both methods rely on the manipulation of pH and ionic strength to separate, elute, and purify charged biomolecules, making them versatile techniques with biotechnological and pharmaceutical applications.

Applications in antibody purification and optimization of pH and ionic strength: Ion exchange chromatography is an effective technique for antibody purification that utilizes charge interactions to separate antibodies from other proteins based on their net charge at specific pH conditions. Both CEC and AEC are used, with separations performed by adjusting the pH of the mobile phase. If unsure of the net charge of your antibody, running an isoelectric focusing gel is a quick and easy way to determine this.

Size exclusion chromatography (SEC)

SEC is a technique that separates molecules by size, allowing larger molecules like antibodies to elute first from a column packed with porous beads while smaller molecules are retained. It serves as a crucial polishing step in antibody purification, effectively removing aggregates and impurities.

SEC is a vital technique for purifying antibody fragments such as fragment antigen binding (Fab) and single chain variable fragments (scFv), as it effectively separates these smaller molecules from larger contaminants and aggregates while maintaining their stability and biological activity, ensuring high purity for therapeutic applications.

SEC offers several advantages, including gentle separation of sensitive biomolecules, high purity by removing contaminants and aggregates, and straightforward operation without the need for harsh chemicals. It is best used as a polishing step following affinity or ion exchange chromatography, particularly when there is a need to remove aggregates or for final purification to meet regulatory standards in pharmaceutical applications. It is important to know the exclusion limit of your chosen SEC resin before proceeding.

Precipitation methods

Precipitation methods, using reagents like ammonium sulfate and polyethylene glycol, offer a simple and cost-effective way to separate antibodies from antigens by precipitating antibody complexes while leaving free antigens in solution.

Precipitation using ammonium sulfate or polyethylene glycol

Ammonium sulfate and polyethylene glycol (PEG) are effective reagents for separating free antigens from antigen-antibody complexes, which is essential in various immunoassays to determine the distribution of antigens. By using specific concentrations, these substances precipitate the antibody molecules and complexes while leaving free antigens in the solution, enabling a separation process based on differences in solubility.

Comparison of precipitation vs. chromatography techniques

Precipitation and chromatography are both used for purifying biomolecules. Precipitation is based on the solubility of molecules, while chromatography separates substances based on their chemical or physical interactions.

Precipitation is a simpler, cost-effective method suitable for initial concentration. In contrast, chromatography offers higher purity and specificity, making it ideal for final purification and analytical applications. The choice between these techniques depends on factors like desired purity, yield, and the nature of the biomolecule, often leading to a combined approach for optimal results.

Alternative antibody purification techniques

As antibody applications in therapeutics and diagnostics expand, new purification techniques are continually being developed to enhance efficiency, scalability, and specificity. These emerging methods address challenges associated with traditional techniques and adapt to the evolving needs of the industry.

Immobilized metal affinity chromatography (IMAC)

IMAC yields varying degrees of recombinant antibody purity influenced by host cell protein composition and the choice of metal ligands, with nickel-nitrilotriacetic acid (Ni-NTA) being the most common for His-tagged protein purification. However, alternatives like iminodiacetic acid (IDA) and metal ions such as zinc and copper offer valuable options, particularly in terms of environmental safety and selectivity, although they may result in higher host cell protein content due to complex interactions and binding clusters on the protein surface.

Multimodal chromatography

Multimodal chromatography has gained prominence in the purification of biotherapeutics due to its ability to combine multiple separation modes, typically integrating ion exchange and hydrophobic interactions, which enhances selectivity and sensitivity. It is used as a versatile protein purification tool for enhanced separation. In addition, shelled chromatography resins prevent large molecular weight contaminants from entering the core and interacting with the functional group and binding site.

Continuous chromatography and membrane-based techniques

Continuous chromatography involves the continuous flow of the mobile phase through the stationary phase in a column, allowing for the uninterrupted processing of samples. The development and optimization of a purification process for monoclonal antibodies using two continuous chromatography steps is beneficial over traditional batch chromatography.

Continuous methods, particularly sequential multicolumn chromatography (SMCC), enhance productivity, reduce buffer consumption, and minimize resin volume, resulting in a more efficient and effective purification process. Membrane chromatography is a chromatographic technique that utilizes a membrane with macropores to allow the convective flow of solute, eliminating intra-bead diffusion and enabling high flow-rate operations. Thus, it helps in high-throughput purification and scalability for large-scale production of antibodies.

Monolithic chromatography

Polymer monoliths serve as an efficient platform for antibody purification, effectively meeting the growing demand for monoclonal antibodies and engineered antibody structures as therapeutics. They offer practical advantages, including rapid analysis, reduced sample volume requirements, and enhanced target molecule enrichment, making them valuable for large-scale antibody purification.

Single-use technologies

Single-use technologies include disposable systems and components used in the biopharmaceutical industry to purify antibodies and other biomolecules. Such technologies are rapidly transforming biopharmaceutical manufacturing, particularly in the production of antibody-drug conjugates and cell and gene therapies. It also facilitates the development of new monoclonal antibody therapies and vaccines for various diseases.

These systems offer solutions that enable process intensification and continuous processing. However, challenges remain in advancing single-use sensors, developing new materials, and standardizing designs for better interchangeability.

Antibody purification protocols

The antibody purification protocol involves four main steps—column and buffer preparation, serum running, washing, and elution—followed by dialysis and concentration.

• Buffer and column preparation: Prepare the necessary buffers, which can be stored at 4°C for up to two weeks. Suspend the resin in the loading buffer and set up the column.
• Buffer dilution and serum running: Dilute the serum with the same buffer to an appropriate volume before applying it to the column.
• Washing and elution: Wash and elute the antibody using an elution buffer. Suitable elution buffers and can acidic, alkali, denaturing or chaotropic salts.
• Dialysis and concentration: Collect the fractions and measure the absorbance at 280 nm to determine the antibody concentration. Pool the fractions with the highest absorbance and dialyze the antibody into the desired buffer using dialysis or ultrafiltration. Add any stabilizer or preservatives where appropriate.

Quality control and characterization

A high-performance liquid chromatography (HPLC) purification method allows for the rapid and reliable isolation of highly pure bispecific monoclonal antibodies from ascites fluid, utilizing a protein A column for immunoglobulin G separation followed by hydroxyapatite chromatography for further refinement.

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and capillary gel electrophoresis (CGE) methods with UV detection provide a reproducible approach for evaluating monoclonal antibody purity, demonstrating applicability across various stages of mAb development and validated for regulatory compliance.

SEC is crucial for the large-scale purification of full-length humanized IgG monoclonal antibodies, ensuring high yield, extreme purity, and compliance with regulatory standards in the biotechnology industry.

Studies have reported consistently maintained the quality of antibodies across various purification processes, including SEC and CEC. Furthermore, adjustments in buffer pH and conductivity had minimal impact on antibody yield and purity, resulting in recovery rates between 87% and 89%. This demonstrates the robustness of the antibody purification method under different operational conditions.

Functionality testing

Direct cell-based ELISAs are effective for the rapid detection of cell-surface antigens and can be used to profile antigen expression using reporter-labeled antibodies. This method is used for identifying immunohistochemistry-reactive antibodies and aids in the selection of hybridoma-derived antibodies for further ELISA development, offering sensitivity comparable to flow cytometry and the capability for multiplex analysis. The amount of product produced is directly proportional to the antibodies present.

Stability and storage

Long-term stability and storage of monoclonal antibodies are essential for their development as biologics, and early prediction from accelerated stability studies is increasingly important despite current limitations in robustness. A combination of accelerated stability studies and a first-order degradation kinetic model can effectively predict the long-term stability of various monoclonal antibody formulations over multiple years. This prevents aggregation and demonstrates improved accuracy and speed compared to classical methods while contributing to the refinement of regulatory guidelines for biologics.

Troubleshooting common antibody purification issues

Antibody purification often comes with challenges that can affect yield, purity or functionality. Identifying and addressing these issues early ensures that the final product meets the desired standards. Here are some common antibody purification problems:

Low yield, protein aggregation, and contamination

Antibody purification is an essential step in therapeutic processes. However, it undergoes several purification issues like low yield, protein aggregation and contamination. Understanding and reducing these problems is critical for enhancing the efficiency of antibody production.

Protein aggregation during biotherapeutic manufacturing can be controlled by optimizing environmental conditions and process strategies, with steps in place to minimize and remove aggregates at scale while ensuring equipment compatibility. Contamination during antibody purification can lead to misidentified samples, potentially compromising experiments and results. Still, it can be detected and mitigated using methods like lattice parameter searches and molecular replacement with common contaminants.

Adjusting parameters like pH, ionic strength, and flow rates

Adjusting parameters like pH, ionic strength, and flow rates significantly influences antibody purification. Optimal separation is achieved at pH 7.4, and varying effects on retention depend on flow rate and ionic strength. Low-pH viral inactivation during antibody purification can cause protein aggregation, especially in IgG4 antibodies, due to unfolding at acidic pH levels, leading to Fc receptor binding issues and reduced molecular stability, but this can be mitigated by optimizing pH transitions and mixing using computational fluid dynamics.

Strategies for improving antibody recovery and maintaining bioactivity

Strategies such as mild elution conditions, aqueous two-phase systems, and non-affinity polymers have been effective in reducing aggregation and improving yield to optimize antibody recovery and maintain bioactivity during purification. Additionally, techniques like PEG precipitation with anion-exchange chromatography, reverse micellar extraction, and histidine-immobilized adsorbents ensure high recovery rates while preserving the antibody's functional integrity.

Scale-up considerations for antibody purification

Scaling up antibody purification from small laboratory quantities to larger, industrial-scale production presents unique challenges. The transition from research-grade to commercial-grade purification requires careful optimization of methods, equipment, and processes to ensure that yield, purity, and functionality are maintained.

Transitioning from lab-scale to industrial-scale purification

Scaling up antibody purification from the lab scale to the industrial scale requires careful consideration of strategies such as high throughput and automation, continuous chromatography, and resin optimization to ensure efficiency, cost-effectiveness, and product quality. Using semi-automated systems, continuous multicolumn chromatography, and scale-down models can significantly enhance productivity while addressing practical challenges in buffer preparation and filtration, ultimately leading to improved process consistency and reduced costs.

Cost-effectiveness and challenges in large-scale antibody production

Large-scale mAb production has become more cost-effective due to advancements in upstream processes and the adoption of hybrid production modes, which can lower manufacturing costs by optimizing both upstream and downstream operations. However, challenges such as increasing product titers, impurity compositions, and the high costs associated with facilities and continuous processes necessitate ongoing technological developments and the exploration of alternative expression systems like Escherichia coli and plant cells to enhance efficiency and cost-effectiveness further.

Antibody purification - Trends and technologies

As the demand for high-quality, highly purified antibodies continues to grow, advancements in purification technologies are evolving to meet the challenges of efficiency, scalability, and cost-effectiveness. Here are the key trends and emerging technologies in antibody purification:

Novel purification matrices and synthetic ligands

The increasing demand for recombinant therapeutic antibodies has led to efforts to improve downstream processing, especially in developing better affinity chromatography matrices for efficient and cost-effective purification. Novel alternative affinity ligands, such as artificial binding proteins, peptides, and synthetic small molecules, are emerging as promising tools for enhanced antibody purification in chromatography and other applications.

Automation and high-throughput antibody purification

Automation in antibody purification processes includes integrating AI-driven methods and advanced decision-support systems, significantly accelerating discovery, development, and functional screening in biopharmaceutical research. High-throughput (HTP) antibody purification processes using automated workflows help in the quick purification of over 2000 antibodies per day from microscale cultures, achieving high recovery rates and producing enough high-quality antibodies for functional and molecular characterization.

Role of artificial intelligence in process optimization

Artificial intelligence (AI) in antibody purification process optimization allows for the exploration of significantly more sequence diversity compared to traditional methods, accelerating drug discovery and improving safety and efficacy profiles. By integrating AI-driven in silico predictions with automated high-throughput wet lab workflows for protein expression, purification, and characterization, biopharmaceutical companies can rapidly generate large volumes of high-quality data for AI training and validation, enhancing the efficiency of biologics development.

FAQs

What is antibody purification and conjugation?

Antibody purification is the process of isolating antibodies from biological mixtures and removing contaminants to ensure their efficacy and safety for research, diagnostic, and therapeutic applications. Antibody conjugation involves chemically linking purified antibodies to substances like enzymes, fluorophores, or drugs, enhancing their functionality for specific uses such as imaging, detection, or targeted therapies.

How to isolate and purify antibodies?

Antibodies can be isolated and purified from sources like serum or cell culture supernatant using methods such as affinity chromatography, ion exchange, and size exclusion chromatography, which remove contaminants and ensure high purity. Pre-purification steps like cell lysis, centrifugation, and filtration are essential to prepare the samples for effective purification.

What method is used to purify monoclonal antibodies?

Monoclonal antibodies are typically purified using affinity chromatography, with protein A and G columns being the most common choices. These proteins bind specifically to the Fc region of antibodies, allowing for selective purification. After antibody binding, it is eluted from the column using a low-pH buffer, providing a highly pure and concentrated product. This method ensures both high specificity and yield.

What is the isolation and purification of antibodies?

Isolation and purification of antibodies involve separating antibodies from a complex mixture, such as serum or cell culture supernatant, to obtain a homogeneous sample suitable for research or therapeutic use. This process typically includes techniques like non-chromatographic and chromatographic methods to selectively capture and purify specific antibodies based on their unique properties.

What percentage of purified antibodies is antigen-specific?

The percentage of purified antibodies that are antigen-specific can vary significantly based on the purification method and the initial purity of the antibody preparation. In well-optimized affinity purification processes, it is possible to achieve higher specificity (>95%) for the target antigen. Still, initial preparations may contain varying levels of non-specific antibodies, affecting the final specificity.